| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811534 Purine-based compounds for inclusion into oligonucleotides |
| 09/22/1998 | US5811524 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 09/22/1998 | US5811523 Antibodies to natural killer stimulatory factor |
| 09/22/1998 | US5811520 Human phospholipase inhibitor protein |
| 09/22/1998 | US5811518 Polypeptide having specified amino acid sequence, capable of being specifically bound by antibody |
| 09/22/1998 | US5811517 Polynucleotides encoding intercellular adhesion molecule, and variants which display one or more ligand/receptor binding biological activities; cytoplasmic tail variants |
| 09/22/1998 | US5811516 Tyro-3 protein tyrosine kinase |
| 09/22/1998 | US5811514 Integrin blocking molecule |
| 09/22/1998 | US5811512 Binding to g-protein-linked receptors, substance p receptor; hormone inhibitors |
| 09/22/1998 | US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders |
| 09/22/1998 | US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid |
| 09/22/1998 | US5811441 Inhibition of platelet aggregation; treatment of autoimmune diseases |
| 09/22/1998 | US5811440 Anticarcinogenic actinomadura culture products |
| 09/22/1998 | US5811434 Methods and compositions for stimulating neurite growth |
| 09/22/1998 | US5811416 Administering to treat disorders such as dysmenorrhea, preterm labor, preeclampsia, or fetal growth retardation; also hormone replacement therapy, hypertension |
| 09/22/1998 | US5811410 Nonsteroidal antiinflammatory drugs |
| 09/22/1998 | US5811402 Anticoagulants, thrombin inhibitors |
| 09/22/1998 | US5811401 A cyclic pentosidine-arginine-lysine dipeptide for treating, analyzing the diabetes, renal disorder and aging |
| 09/22/1998 | US5811400 Analgesics, immunosuppressive agents |
| 09/22/1998 | US5811399 Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants |
| 09/22/1998 | US5811398 Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues |
| 09/22/1998 | US5811397 Mammalian augmenter of liver regeneration and variants thereof |
| 09/22/1998 | US5811396 TRK tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/22/1998 | US5811395 Relaxin analogs and derivatives methods and uses thereof |
| 09/22/1998 | US5811394 Technetium-99m labeled polypeptides for imaging |
| 09/22/1998 | US5811393 Heparin binding mitogen with homology to epidermal growth factor (EGF) |
| 09/22/1998 | US5811392 Conformationally constrained backbone cyclized peptide analogs |
| 09/22/1998 | US5811391 Cyclic CS-1 peptidomimetics, compositions and methods of using same |
| 09/22/1998 | US5811390 Use of beta HCG for the control of retroviral infection |
| 09/22/1998 | US5811389 Inhibiting platelet aggregation; blood disorders |
| 09/22/1998 | US5811388 Delivery of drugs to the lower GI tract |
| 09/22/1998 | US5811387 Enzyme resistant oligo- or poly-peptoid which may selectively bind to polypeptide or effector molecule; mimetics, peptoid libraries |
| 09/22/1998 | US5811304 Nucleic acid molecules encoding retinoblastoma protein-interacting zinc finger proteins |
| 09/22/1998 | US5811301 In vitro method for producing differentiated universally compatible human blood cells |
| 09/22/1998 | US5811300 TNF-α ribozymes |
| 09/22/1998 | US5811288 Isoform gene for focal adhesion protein paxillin |
| 09/22/1998 | US5811284 Nucleic acids encoding kp43 protein and antigenic fragments thereof |
| 09/22/1998 | US5811279 Activation of prothrombin to thrombin |
| 09/22/1998 | US5811275 HIV-specific ribozymes |
| 09/22/1998 | US5811267 For drug or toxin targeting, imaging, therapy |
| 09/22/1998 | US5811265 Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
| 09/22/1998 | US5811264 Mutated protein having sequence with nonproline amino acid replacement for proline at position four, which is not methylated at its n-terminus when expressed in bacteria |
| 09/22/1998 | US5811263 A cloned dna molecule which encodes human endothelin-3-protein; hypertensive agents and has a antivasoconstrictor activity |
| 09/22/1998 | US5811261 Transfecting eukaryotic cells with an expression vector |
| 09/22/1998 | US5811249 Control of infectious microorganisms by modulation of chorionic gonadotropin-related protein activity |
| 09/22/1998 | US5811245 Antibodies that specifically bind to ALK-7, a novel serine threonine kinase receptor |
| 09/22/1998 | US5811238 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 09/22/1998 | US5811237 Sequence coding for protein expressed by campylobacter pylori |
| 09/22/1998 | US5811128 Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor |
| 09/22/1998 | US5811127 Desferrioxamine oral delivery system |
| 09/22/1998 | US5811106 Polypeptides produced by human malaria parasites |
| 09/22/1998 | US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling |
| 09/22/1998 | US5811096 Comprises urate oxidase and poloxamer in buffered aqueous medium |
| 09/22/1998 | US5811005 Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix |
| 09/22/1998 | US5810970 Mixing cellulosic material, diluting and adding an aluminum rosin forming a pulp slurry |
| 09/22/1998 | CA2117584C Gels for encapsulation of biological materials |
| 09/22/1998 | CA2099138C Chondroitinase, process for preparing the same, and pharmaceutical composition comprising the same |
| 09/22/1998 | CA2056911C Hiv protease inhibitors |
| 09/22/1998 | CA2050679C Preparation of liposome and lipid complex compositions |
| 09/21/1998 | CA2232828A1 Humanized anti-human fas antibody |
| 09/21/1998 | CA2232637A1 Composition containing a compound which directly or indirectly modifies the activity of endogenous t1-m protein |
| 09/19/1998 | CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor |
| 09/18/1998 | CA2200501A1 Glutathione antioxidant eye drops |
| 09/17/1998 | WO1998040738A1 Prostate specific antigen substrates |
| 09/17/1998 | WO1998040516A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 09/17/1998 | WO1998040514A1 Clock gene and gene product |
| 09/17/1998 | WO1998040508A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | WO1998040507A1 Expression of a modified foamy virus envelope protein |
| 09/17/1998 | WO1998040498A2 Immunoadhesins and methods of production and use thereof |
| 09/17/1998 | WO1998040497A2 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 09/17/1998 | WO1998040495A1 Doublin, a gene involved in neuronal development and uses therefor |
| 09/17/1998 | WO1998040494A1 Novel rna editing enzyme |
| 09/17/1998 | WO1998040493A1 Fiv vaccine |
| 09/17/1998 | WO1998040492A1 Compositions and methods for elimination of unwanted cells |
| 09/17/1998 | WO1998040489A1 Antisense base sequences |
| 09/17/1998 | WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | WO1998040487A1 Angiogenin receptor, compositions and methods related thereto |
| 09/17/1998 | WO1998040486A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040485A1 Human secreted protein, ba3.1, and polynucleotides encoding same |
| 09/17/1998 | WO1998040484A1 Intracellular amyloid-beta binding (erab) polypeptide |
| 09/17/1998 | WO1998040483A2 28 human secreted proteins |
| 09/17/1998 | WO1998040482A1 Growth factor receptor binding protein |
| 09/17/1998 | WO1998040480A1 A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses |
| 09/17/1998 | WO1998040479A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | WO1998040478A2 Antisense inhibition of human stat-6 |
| 09/17/1998 | WO1998040475A1 Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same |
| 09/17/1998 | WO1998040474A2 Activated vitamin k-dependent blood factor and method for the production thereof |
| 09/17/1998 | WO1998040408A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | WO1998040406A1 Calcium phosphopeptide complexes |
| 09/17/1998 | WO1998040405A1 Antithrombin protein and dna sequences |
| 09/17/1998 | WO1998040404A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040403A1 Psca: prostate stem cell antigen |
| 09/17/1998 | WO1998040402A2 INHIBITORS OF G-PROTEIN-β/η SUBUNIT FUNCTION |
| 09/17/1998 | WO1998040401A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | WO1998040400A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus |
| 09/17/1998 | WO1998040102A1 Cytoprotective agents comprising monoamine oxidase inhibitors |
| 09/17/1998 | WO1998040098A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 09/17/1998 | WO1998040096A1 Preventives and/or remedies for multiple organ failure |
| 09/17/1998 | WO1998040095A1 Preventive and therapeutic compositions for drug induced nephropathy and hepatitis |